X4 Pharmaceuticals Q1 EPS $(0.16) Beats $(0.20) Estimate, Sales $2.708M Miss $3.200M Estimate
Benzinga Newsdesk 5 months ago
EarningsEarnings BeatsEarnings MissesNews
X4 Pharmaceuticals (NASDAQ:XFOR) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.20) by 20 percent. This is a 500 percent decrease over earnings of $0.04 per share from the
X4 Pharmaceuticals (NASDAQ:XFOR) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.20) by 20 percent. This is a 500 percent decrease over earnings of $0.04 per share from the same period last year. The company reported quarterly sales of $2.708 million which missed the analyst consensus estimate of $3.200 million by 15.38 percent. This is a 90.60 percent decrease over sales of $28.800 million the same period last year.